|
|
Volumn 25, Issue 8 SUPPL., 2005, Pages
|
|
Survival factors for treatment of retinal degenerative disorders: Preclinical gains and issues for translation into clinical studies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACIDIC FIBROBLAST GROWTH FACTOR;
BASIC FIBROBLAST GROWTH FACTOR;
CILIARY NEUROTROPHIC FACTOR;
FIBROBLAST GROWTH FACTOR;
INTERLEUKIN 1BETA;
NEUROTROPHIC FACTOR;
NEUROTROPHIN 3;
RECOMBINANT ACIDIC FIBROBLAST GROWTH FACTOR;
RECOMBINANT CILIARY NEUROTROPHIC FACTOR;
RECOMBINANT FIBROBLAST GROWTH FACTOR;
RECOMBINANT INTERLEUKIN 1BETA;
NERVE GROWTH FACTOR;
BLOOD RETINA BARRIER;
CONFERENCE PAPER;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG SPECIFICITY;
DRUG TARGETING;
GENE DELIVERY SYSTEM;
GENE EXPRESSION;
GENE MUTATION;
NEUROPROTECTION;
NONHUMAN;
PHOTORECEPTOR CELL;
PIGMENT CELL;
PIGMENT EPITHELIUM;
RETINA CONE;
RETINA DEGENERATION;
TOXICITY TESTING;
ANIMAL;
CLINICAL TRIAL;
DRUG SCREENING;
HUMAN;
REVIEW;
ANIMALS;
CLINICAL TRIALS;
DRUG DELIVERY SYSTEMS;
DRUG EVALUATION, PRECLINICAL;
HUMANS;
NERVE GROWTH FACTORS;
RETINAL DEGENERATION;
|
|
EID: 33644875055
PISSN: 0275004X
EISSN: None
Source Type: Journal
DOI: 10.1097/00006982-200512001-00009 Document Type: Conference Paper |
|
Times cited : (20)
|
|
References (3)
|
